Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NDA for Plenaxis denied FDA approval

June 14, 2001

Takeda compounds inhibit testosterone synthesis, useful for sex steroid-dependent disorders

June 13, 2001

Preparation and methods of use of new uPAR antagonists

June 13, 2001

Novel taxanes with improved profile designed at Daiichi

June 13, 2001

First launch for Myocet, a new breast cancer therapy

June 13, 2001

pHyde, a new target gene in the treatment of prostate cancer

June 13, 2001

Adenoviral transfer of PTEN as a promising anticancer gene therapy

June 13, 2001

Enrollment in second rubitecan trial completed, triggering milestone payment

June 13, 2001

NIH awards Direct Therapeutics SBIR grant

June 13, 2001

U.S. patent covers cysteine protease inhibitors identified at Naeja

June 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....